Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing Guaifenesin may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
you can help provide more information on the safety of this medicine. 3. Further information If you accidentally take too much contact your doctor or pharmacist straight away. Very large doses can cause sickness (nausea and vomiting). Take the pack with you to show which medicine you have swallowed.
93006712103
P4 The active ingredients per 15ml are: guaifenesin 200mg The other ingredients are: water, glycerin (E422), sorbitol (E420), sodium cyclamate (E952), sodium saccharin (E954), carrageenan , potassium sorbate (E202), anise, blackcurrant and menthol, flavours [contains triacetin (E1518), propylene glycol (E1520)], colours ponceau 4R (E124) and caramel (E150). What the medicine looks like Covonia Chesty Cough Sugar Free Syrup is a deep red coloured, thick, syrupy liquid which smells of anise, blackcurrant and menthol. It is supplied in 150ml and 300ml bottles. The leaflet was last revised in March 2021.
Covonia Chesty Cough Sugar Free Syrup comes as oral solution. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.
The active substance in Covonia Chesty Cough Sugar Free Syrup is guaifenesin.
This leaflet reproduces the patient information leaflet approved for Covonia Chesty Cough Sugar Free Syrup, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
To loosen stubborn mucus and clear chesty coughs.
For oral use.
Adults, the Elderly and Children 12 years and over: 3 x 5ml spoonfuls.
The dose should not be repeated more frequently than every 6 hours.
Not more than 3 doses should be taken in any 24 hours.
Do not take more medicine than the label tells you to.
This product is contraindicated in children under the age of 12 years (see section 4.3).
Do not take with any other cough and cold medicine.
Known hypersensitivity to any of the ingredients - Porphyria.
Not to be used in children under the age of 12 years.
Keep out of the sight and reach of children.
If symptoms persist consult your doctor.
Ingredients with specified warnings
This medicine contains less than 1mmol sodium (23mg) per dose, that is to say essentially 'sodium-free'.
This medicine contains 4.4g sorbitol in each 15ml dose. Patients with rare hereditary problems of fructose intolerance should not take this medicine.
This medicine contains 25.1mg propylene glycol in each 15ml dose.
Contains Ponceau 4R E124 which may cause allergic reactions.
None reported.
Pregnancy
There are no or limited amount of data from the use of Guaifenesin in pregnant women. As a result, this product is not recommended during pregnancy or in women of childbearing potential not using contraception.
Lactation
It is unknown whether Guaifenesin/metabolites are excreted in human milk therefore a risk to newborns/infants cannot be excluded. As a result, this product is not recommended during breast-feeding.
None stated.
Adverse reactions are listed below by system organ class and frequency. Frequencies are defined as:
Very common (≥1/10), common (≥1/100 to <1/10), uncommon (≥1/1000 to <1/100), rare (≥1/10,000 to<1/1000) and very rare (<1/10,000), not known (cannot be estimated from the available data)
Immune system disorders
Unknown: hypersensitivity reactions
Gastrointestinal disorders
Unknown: Abdominal discomfort, nausea and vomiting
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for 'MHRA Yellow Card' in the Google Play or Apple App Store.
Very large doses of Guaifenesin can cause nausea and vomiting. Vomiting should be treated by fluid replacement and monitoring of electrolytes.
Medicines sold in Romania with the same active substance: Cunoscut în România ca
Same active substance. The strength, the form and whether you need a prescription can differ. Always ask a pharmacist before you switch. Romanian medicines in the UK →
Medicines sold in Poland with the same active substance: W Polsce znany jako
Same active substance. The strength, the form and whether you need a prescription can differ. Always ask a pharmacist before you switch. Polish medicines in the UK →
Ask anything about Covonia Chesty Cough Sugar Free Syrup. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.
We use essential cookies to make the site work. We would also like to set optional cookies to understand how the site is used, so we can improve it. We will not set optional cookies unless you accept. See our cookie policy and privacy policy.